Literature DB >> 9794397

Human endothelial cells induce and regulate cytolytic T cell differentiation.

B C Biedermann1, J S Pober.   

Abstract

We compared the capacity of cultured human endothelial cells (EC) vs B lymphoblastoid cells (BLC) from the same donor to stimulate allogeneic CD8+ T cells to differentiate into CTL, assaying for allorestricted cytotoxicity, T cell growth, IFN-gamma secretion, and perforin expression. The input cell number affected specificity and potency of the resulting CTL. At low input (<10(5) cells/ well), anti-EC CTL were rarely detected. At high input (>10(6) cells/well), anti-EC CTL developed that displayed unrestricted, low-titer killing and an unstable phenotype. At intermediate input (1.0-2.5 x 10(5) cells/well), classical class I MHC-restricted, CD8+, and perforin-positive anti-EC CTL developed with reproducible frequencies. However, under all conditions EC were less efficient stimulators than BLC from the same donor. Anti-EC CTL did not kill BLC, whereas anti-BLC CTL killed BLC and EC from the same donor with comparable efficiency. When CD8+ T lymphocytes were grown in the presence of EC and BLC together, the differentiation of anti-BLC CTL was completely suppressed, while the anti-EC response was intact. The inhibition of the allogeneic anti-BLC CTL response was independent of T cell-EC contact, and proliferation of CD8+ T cells was inhibited by EC-conditioned medium. We conclude that EC are competent but less efficient activators of CTL differentiation than are BLC and that EC actively regulate differentiation and/or expansion of allospecific CTL.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9794397

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

Review 1.  Immunobiology of human vascular endothelium.

Authors:  J S Pober
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  A rendezvous before rejection: where do T cells meet transplant antigens?

Authors:  David M Briscoe; Mohamed H Sayegh
Journal:  Nat Med       Date:  2002-03       Impact factor: 53.440

3.  Blocking MHC class II on human endothelium mitigates acute rejection.

Authors:  Parwiz Abrahimi; Lingfeng Qin; William G Chang; Alfred L M Bothwell; George Tellides; W Mark Saltzman; Jordan S Pober
Journal:  JCI Insight       Date:  2016-01-21

4.  Human endothelial cells enhance human immunodeficiency virus type 1 replication in CD4+ T cells in a Nef-dependent manner in vitro and in vivo.

Authors:  Jaehyuk Choi; Jason Walker; Sergei Boichuk; Nancy Kirkiles-Smith; Nicholas Torpey; Jordan S Pober; Louis Alexander
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 5.  Participation of blood vessel cells in human adaptive immune responses.

Authors:  Jordan S Pober; George Tellides
Journal:  Trends Immunol       Date:  2011-10-24       Impact factor: 16.687

6.  Nanodelivery of Mycophenolate Mofetil to the Organ Improves Transplant Vasculopathy.

Authors:  Mayuko Uehara; Baharak Bahmani; Liwei Jiang; Sungwook Jung; Naima Banouni; Vivek Kasinath; Zhabiz Solhjou; Jing Zhao; Farideh Ordikhani; Munhyung Bae; Nasim Annabi; Martina M McGrath; Reza Abdi
Journal:  ACS Nano       Date:  2019-09-25       Impact factor: 15.881

7.  The Biology and Molecular Basis of Organ Transplant Rejection.

Authors:  Philip F Halloran; Gunilla Einecke; Majid L N Sikosana; Katelynn Madill-Thomsen
Journal:  Handb Exp Pharmacol       Date:  2022

8.  Significant Differences in Antigen-Induced Transendothelial Migration of Human CD8 and CD4 T Effector Memory Cells.

Authors:  Thomas D Manes; Jordan S Pober
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-07-21       Impact factor: 8.311

Review 9.  Endothelial cells in allograft rejection.

Authors:  Rafia S Al-Lamki; John R Bradley; Jordan S Pober
Journal:  Transplantation       Date:  2008-11-27       Impact factor: 4.939

Review 10.  Advanced in vitro Research Models to Study the Role of Endothelial Cells in Solid Organ Transplantation.

Authors:  Daphne M Peelen; Martin J Hoogduijn; Dennis A Hesselink; Carla C Baan
Journal:  Front Immunol       Date:  2021-02-10       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.